| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.9 |